CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors The year in cardiovascular medicine 2020: heart failure and cardiomyopathies Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol

Editorial17 Nov 201

JOURNAL:Circulation. Article Link

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF

Martinez FA, Serenelli M, Nicolau JC et al. Keywords: dapagliflozin; HFrEF; efficacy; safety

FULL TEXT PDF